Pharmacists in Decatur, IL Accepting Medicare
68 Pharmacists found. Showing 61 - 68
 Roberta Jo Martin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1311 N State Route 48, Decatur, IL 62526 Phone: 217-429-1988 Fax: 217-429-9577 |
 Mr. Brian Keith Tatro, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3070 N Water St, Decatur, IL 62526 Phone: 217-877-1327 Fax: 309-877-1328 |
Dr. Ashley Thais, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 3035 E Mound Rd, Decatur Cboc, Decatur, IL 62526 Phone: 217-875-2670 |
Dr. Carlton Dean, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1311 N State Route 48, Decatur, IL 62526 Phone: 217-429-1988 Fax: 217-429-9577 |
Saima Farooqui Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2060 N Edward St, Decatur, IL 62526 Phone: 217-358-5952 |
Matthew L Krager, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1311 N State Route 48, Decatur, IL 62526 Phone: 217-429-1988 Fax: 217-429-9577 |
Jamie Nicole Guthrie, PH Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 3070 N Water St, Decatur, IL 62526 Phone: 217-877-1327 |
Bhaumik Thakkar Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 625 W Pershing Rd, Decatur, IL 62526 Phone: 217-875-2751 |
News Archive
Researchers develop model to assess prostate cancer risk
Researchers have developed a model to predict prostate cancer for men who undergo a prostate biopsy. The details of the risk calculator appear in the Journal of the National Cancer Institute.
Alphavirus vector induce immune responses in people with advanced cancer: Researchers
There are several challenges to be overcome if therapeutic anticancer vaccines, which are designed to boost the patient's anticancer immune response, are to be successfully developed. For example, the viruses used to deliver the tumor protein to the patient's immune system are themselves targeted by the patient's immune system, inducing neutralizing and suppressive responses. But now, a team of researchers, led by Michael Morse, at Duke University Medical Center, Durham, has developed a way to overcome these neutralizing and suppressive responses by using an alphavirus packaged in virus-like replicon particles.
Rally Foundation distributes $700,000 nationwide to support childhood cancer research
Rally Foundation, a national non-profit organization committed to research to fight childhood cancer, has announced its annual funding allocation for 2011 and has selected 15 hospitals across the country to receive more than $700,000.
Nanolek, Green Cross sign strategic deal to commercialize biologics in the Russian market
Green Cross, a South Korean biopharmaceutical company, and Nanolek, a Russian pharmaceutical company, today announced that they have entered into a strategic partnership agreement for the commercialisation of Green Cross' biologics in the Russian market.
GW clinical trial aims to identify novel modalities to reduce seizures in MTLE patients
A first-of-its-kind clinical trial at the George Washington University Medical Faculty Associates employs low-frequency deep brain stimulation to potentially help reduce epileptic seizures in patients with mesial temporal lobe epilepsy (MTLE) - the most common type of focal epilepsy that often necessitates surgical resection of the temporal lobe, risking memory function.
› Verified 4 days ago
Counselors
Pharmacists
Dentists
Clinical Social Workers
Occupational Therapists